Phase II trials can be designed in several ways, including single-arm and randomized trials. In a single-arm trial, all participants receive the experimental treatment. In contrast, a randomized trial involves two or more groups, with one group receiving the standard treatment or a placebo, and the other(s) receiving the experimental treatment. This design allows for a direct comparison of outcomes, providing more robust efficacy data.
